Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€187.15

€187.15

1.190%
2.25
1.190%
€207.72
 
18.07.24 / Tradegate WKN: 895878 / Symbol: RMD / Name: ResMed / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Resmed Inc. Stock

There is an upward development for Resmed Inc. compared to yesterday, with an increase of €2.25 (1.190%).
With 19 Buy predictions and not the single Sell prediction the community is currently very high on Resmed Inc..
With a target price of 207 € there is a slightly positive potential of 10.61% for Resmed Inc. compared to the current price of 187.15 €.

Pros and Cons of Resmed Inc. in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Resmed Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Resmed Inc. 1.190% 1.740% -5.312% -4.952% 19.394% -12.751% 69.305%
QuidelOrtho Corp. 1.270% 10.345% -3.614% -57.024% -52.816% -69.797% -
Boston Scientific -2.820% -2.113% -2.797% 47.778% 35.109% 94.842% 81.961%
Waters Corp. 2.340% 9.087% 5.983% 20.041% -3.808% -7.484% 52.413%

Comments

Prediction Buy
Perf. (%) 4.82%
Target price 219.740
Change
Ends at 24.06.25

ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $236.00 price target on the stock.
Ratings data for RMD provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -7.50%
Target price 186.840
Change
Ends at 26.04.25

ResMed Inc. (NYSE: RMD) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $205.00 to $200.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -1.47%
Target price 222.054
Change
Ends at 26.04.25

ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $227.00 to $238.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
Show more

News

How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?: https://g.foolcdn.com/editorial/images/782157/mfm_24.jpg
How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?

ResMed has had the market on sleep apnea cornered for a while, but new weight loss drugs might be creeping in. In this podcast, we look at what could change based on recent studies and some other

Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market: https://www.marketbeat.com/logos/articles/med_20240630174256_charty-lly.jpg
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market

Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound. Mounjaro is prescribed for Type 2 diabetes but is

Why ResMed Stock Is Soaring Today: https://g.foolcdn.com/editorial/images/774544/cpap-mask-person.jpg
Why ResMed Stock Is Soaring Today

Shares of ResMed (NYSE: RMD) had soared 16.2% higher as of 11:50 a.m. ET on Friday. The big jump came after the healthcare technology company reported results on Thursday evening for its fiscal 2024